We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNS icon
1251
Scotiabank
BNS
$105B
$2K ﹤0.01%
50
CNTA
1252
DELISTED
Centessa Pharmaceuticals
CNTA
$2K ﹤0.01%
211
COGT icon
1253
Cogent Biosciences
COGT
$6.76B
$2K ﹤0.01%
281
CSTL icon
1254
Castle Biosciences
CSTL
$742M
$2K ﹤0.01%
86
EOLS icon
1255
Evolus
EOLS
$397M
$2K ﹤0.01%
162
ETNB
1256
DELISTED
89bio
ETNB
$2K ﹤0.01%
187
LKFT
1257
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$2K ﹤0.01%
51
KNSA icon
1258
Kiniksa Pharmaceuticals
KNSA
$6.23B
$2K ﹤0.01%
139
LYEL icon
1259
Lyell Immunopharma
LYEL
$318M
$2K ﹤0.01%
46
MGNX icon
1260
MacroGenics
MGNX
$233M
$2K ﹤0.01%
209
NRIX icon
1261
Nurix Therapeutics
NRIX
$2.45B
$2K ﹤0.01%
152
PHAT icon
1262
Phathom Pharmaceuticals
PHAT
$928M
$2K ﹤0.01%
167
REPL icon
1263
Replimune Group
REPL
$454M
$2K ﹤0.01%
200
SIGA icon
1264
SIGA Technologies
SIGA
$240M
$2K ﹤0.01%
270
SPRY icon
1265
ARS Pharmaceuticals
SPRY
$579M
$2K ﹤0.01%
367
TARS icon
1266
Tarsus Pharmaceuticals
TARS
$2.55B
$2K ﹤0.01%
107
TBPH icon
1267
Theravance Biopharma
TBPH
$873M
$2K ﹤0.01%
215
TVTX icon
1268
Travere Therapeutics
TVTX
$5.17B
$2K ﹤0.01%
258
WVE icon
1269
Wave Life Sciences
WVE
$1.12B
$2K ﹤0.01%
349
PETQ
1270
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
ABUS icon
1271
Arbutus Biopharma
ABUS
$847M
$1K ﹤0.01%
395
AMRN
1272
Amarin Corp
AMRN
$297M
$1K ﹤0.01%
67
ARQT icon
1273
Arcutis Biotherapeutics
ARQT
$3.48B
$1K ﹤0.01%
245
ATAI icon
1274
AtaiBeckley Inc
ATAI
$2.66B
$1K ﹤0.01%
468
-20,847
-98% -$25.9K
AVIR icon
1275
Atea Pharmaceuticals
AVIR
$370M
$1K ﹤0.01%
242

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.